首页> 外国专利> A compound derived from naftalen - 5 - 1 - il - 1,3 Dioxane in the form of Pure stereoisomer or mixture of stereoisomers, Said medicine is made up,And Pharmaceutical composition containing Said Compound

A compound derived from naftalen - 5 - 1 - il - 1,3 Dioxane in the form of Pure stereoisomer or mixture of stereoisomers, Said medicine is made up,And Pharmaceutical composition containing Said Compound

机译:一种以纯立体异构体或立体异构体混合物的形式衍生自纳夫塔仑-5-1-il-1,3二恶烷的化合物,制备所述药物,以及包含所述化合物的药物组合物

摘要

1. Compounds in the form of stereoisomers or mixtures of stereoisomers, conforming to the general formula (IA),R1 represents an atom dehydrogeno or a c2-4 linear or branched tar, C3-6 cyclopropyl, C3-6 cyclopropyl or a tar in which phenyl c1-3 may be substituted in a phenyl nuclide; R2 represents a hydrogen atom or a C1-4 linear or branched tar, C3-6 cyclopropyl, C3-6 cycloquilmytio o fenil c1-3 coquilo eventualementesubistuido en el nucleo fenilo; R3 represents a water Xi or C1-4 alcox group or a nr4r5 universal formula group, wherein R4 and R5 respectively represent a hydrogen atom and a C1-4 linear synthetic tar group, A group of c-3-6 cyclopropyl or ungrupo C3-6 cyclopropyl ethyl ester,In a general formula (IB), R represents a hydrogen atom, or a general ch2coy formula group. In this formula group, R represents a hydrogen Xi group, a C1-4 alcoxi group, or a general ch2con1r2 formula group, wherein R1 and R2 are independent of each other, They represent a hydrogen atom or a C1-4 tar group; X represents an oxygen or sulfur atom or a CH2 group; m represents 0 or 1; n represents 0, 1 or 2, in the state of free radicals or acid-induced salts; R1 represents a hydrogen atom or a common preparation group in the total formula. C H2COY,In this case, it also represents a C1-4 alcoxi or ungrupo C1-4 alcoxi group, or a ch2conr4r5 total formula group, wherein R4 and R5 respectively represent an atomic dehidrogeno or C1-4 hydrocarbon group; R2 repeat establishes a piridin-2-ilo group, a piridin-3-ilo group, and a piridin-4-ilo group, A group of 1-methylpyridine-2-ilo, 1
机译:1.符合通式(IA)的立体异构体形式或立体异构体混合物形式的化合物,R 1代表原子脱氢原子或c 2-4线性或支化的焦油,C 3-6环丙基,C 3-6环丙基或焦油。苯基c1-3可被苯基核素取代; R 2代表氢原子或C 1-4直链或支链的焦油,C 3-6环丙基,C 3-6环茴香酸C 1-3缩合最终核糖基。 R 3代表水Xi或C1-4醇基或nr4r5通用通式基团,其中R4和R5分别代表氢原子和C1-4线性合成焦油基团,c-3-6环丙基或非降尘基C3- 6,环丙基乙基酯,在通式(IB)中,R表示氢原子或通式ch 2 coy的式基。在该式基中,R表示氢X 1,C 1-4醇基或一般的ch 2 con1r 2式基,其中R 1和R 2彼此独立,表示氢原子或C 1-4焦油基。 X表示氧或硫原子或CH 2基团; m表示0或1; n以自由基或酸诱导的盐的状态表示0、1或2;通式中,R 1表示氢原子或通常的制备基团。在这种情况下,它还代表C 1-4醇氧基或非Rupo C 1-4醇氧基或ch 2 conr 4r 5通式基团,其中R 4和R 5分别代表原子氢原子或C 1-4烃基。 R 2重复建立piridin-2-ilo基团,piridin-3-ilo基团和piridin-4-ilo基团,即1-甲基吡啶-2-ilo基团1

著录项

  • 公开/公告号AR012908A1

    专利类型

  • 公开/公告日2000-11-22

    原文格式PDF

  • 申请/专利权人 VANMECHELEN EUGEEN;

    申请/专利号AR1998P102585

  • 发明设计人

    申请日1998-06-03

  • 分类号C07D319/06;C07D407/12;C07D405/12;C07D405/06;A61K31/35;A61K31/335;

  • 国家 AR

  • 入库时间 2022-08-22 01:26:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号